STROBE-metagenomics:指导宏基因组学研究报告的STROBE扩展声明
宏基因组学通过测序同时鉴定样本中所有生物的基因组物质,在病原检测、耐药分析等方面应用广泛,但流程复杂且存在技术方法学挑战。为此,一个多学科国际专家组制定了报告指南,涵盖样本处理、核酸提取、测序平台、生物信息学、质量保证、检测限、样本量、验证试验、因果推断、成本及伦理等问题。该指南强调宏基因组学研究的解释需务实谨慎,且领域发展迅速。
要点
- 宏基因组学可提高病原检测和耐药分析的分辨率,但需规范报告。
- 报告应涵盖从样本处理到伦理问题的全流程关键环节。
- 结果解释需谨慎,结合验证试验和因果推断标准。
核心结论
- 宏基因组学研究需遵循STROBE扩展声明进行规范报告,以支持有效推断。
研究设计与样本
- 由多学科国际专家组协调制定报告指南。
主要发现
- 指南涉及样本处理、核酸提取、测序平台、生物信息学、质量保证、检测限、样本量与把握度、验证试验、因果推断标准、成本及伦理问题。
关键数值与推荐
- 指南涵盖样本处理、核酸提取、测序平台、生物信息学、质量保证、检测限、样本量与把握度、验证试验、因果推断标准、成本及伦理问题等报告条目。
临床怎么用
- 临床研究者在设计和报告宏基因组学研究时应参照该指南,确保方法透明和结果可解释。
- 解释宏基因组学结果时需结合验证试验和因果推断标准,保持谨慎。
局限性
- 领域发展迅速,指南需不断更新。
- 指南强调研究需务实和谨慎解释,反映当前方法学挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The term metagenomics refers to the use of sequencing methods to simultaneously identify genomic material from all organisms present in a sample, with the advantage of greater taxonomic resolution than culture or other methods. Applications include pathogen detection and discovery, species characterisation, antimicrobial resistance detection, virulence profiling, and study of the microbiome and microecological factors affecting health. However, metagenomics involves complex and multistep processes and there are important technical and methodological challenges that require careful consideration to support valid inference. We co-ordinated a multidisciplinary, international expert group to establish reporting guidelines that address specimen processing, nucleic acid extraction, sequencing platforms, bioinformatics considerations, quality assurance, limits of detection, power and sample size, confirmatory testing, causality criteria, cost, and ethical issues. The guidance recognises that metagenomics research requires pragmatism and caution in interpretation, and that this field is rapidly evolving.
引用
- Bharucha T, Oeser C, Balloux F, et al. STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies. Lancet Infect Dis. 2020. PMID: 32768390. doi:10.1016/S1473-3099(20)30199-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。